Assessment was done in the morning of RAI administration and included hormonal determinations (thyroid function tests, prolactin, cortisol, and adrenocorticotropic hormone) and evaluation of sleep quality (Pittsburg Sleep Quality Index-PSQI) and anxiety/depression levels (Hospital Anxiety and Depression Scale-HADS). The gene discussed is PRL; the disease is depressive disorder.